Literature DB >> 28108297

The Leukotriene B4 and its Receptor BLT1 Act as Critical Drivers of Neutrophil Recruitment in Murine Bullous Pemphigoid-Like Epidermolysis Bullosa Acquisita.

Tanya Sezin1, Matthias Krajewski2, Adam Wutkowski2, Sadegh Mousavi1, Lenche Chakievska3, Katja Bieber3, Ralf J Ludwig3, Markus Dahlke4, Dirk Rades4, Franziska S Schulze3, Enno Schmidt3, Kathrin Kalies5, Yask Gupta3, Paul Schilf3, Saleh M Ibrahim3, Peter König5, Dominik Schwudke2, Detlef Zillikens1, Christian D Sadik6.   

Abstract

Recruitment of neutrophils and eosinophils into the skin is a hallmark of pemphigoid diseases. The molecular cues regulating granulocyte recruitment into the skin and the individual contributions of neutrophils and eosinophils to pemphigoid diseases are, however, poorly understood. The lipid mediator leukotriene B4 (LTB4) is a potent granulocyte chemoattractant and is abundant in the skin blister fluid of bullous pemphigoid (BP) patients, but its pathogenic significance is unknown. Using mouse models of BP-like epidermolysis bullosa acquisita and of BP, we show that LTB4 and its receptor BLT1 act as critical drivers of neutrophil entry into the skin upon antibody deposition at the dermal-epidermal junction. Mice deficient in 5-lipoxygenase, a key enzyme in LTB4 biosynthesis, or in BLT1 exhibited dramatic resistance to neutrophil recruitment and, consequently, skin inflammation. Accordingly, liquid chromatography-mass spectrometry, used to comprehensively profile lipid mediator generation in the first 48 hours after antibody deposition, showed a pronounced parallel increase in LTB4 and in neutrophils in the skin. Subsequent mechanistic studies in BP-like epidermolysis bullosa acquisita uncovered that neutrophils are necessary for skin inflammation, whereas eosinophils are dispensable, thus identifying neutrophils as major culprits of blister formation. Our results highlight LTB4/BLT1 as absolutely critical drivers of murine pemphigoid disease-like skin inflammation.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28108297     DOI: 10.1016/j.jid.2016.12.021

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  16 in total

Review 1.  Mechanisms of Autoantibody-Induced Pathology.

Authors:  Ralf J Ludwig; Karen Vanhoorelbeke; Frank Leypoldt; Ziya Kaya; Katja Bieber; Sandra M McLachlan; Lars Komorowski; Jie Luo; Otavio Cabral-Marques; Christoph M Hammers; Jon M Lindstrom; Peter Lamprecht; Andrea Fischer; Gabriela Riemekasten; Claudia Tersteeg; Peter Sondermann; Basil Rapoport; Klaus-Peter Wandinger; Christian Probst; Asmaa El Beidaq; Enno Schmidt; Alan Verkman; Rudolf A Manz; Falk Nimmerjahn
Journal:  Front Immunol       Date:  2017-05-31       Impact factor: 7.561

2.  Dual inhibition of complement factor 5 and leukotriene B4 synergistically suppresses murine pemphigoid disease.

Authors:  Tanya Sezin; Sripriya Murthy; Claudia Attah; Malte Seutter; Maike M Holtsche; Christoph M Hammers; Enno Schmidt; Fibi Meshrkey; Sadegh Mousavi; Detlef Zillikens; Miles A Nunn; Christian D Sadik
Journal:  JCI Insight       Date:  2019-08-08

Review 3.  A Review of the Immunologic Pathways Involved in Bullous Pemphigoid and Novel Therapeutic Targets.

Authors:  Mohsen Afarideh; Robert Borucki; Victoria P Werth
Journal:  J Clin Med       Date:  2022-05-18       Impact factor: 4.964

4.  Whole-Genome Expression Profiling in Skin Reveals SYK As a Key Regulator of Inflammation in Experimental Epidermolysis Bullosa Acquisita.

Authors:  Unni K Samavedam; Nina Mitschker; Anika Kasprick; Katja Bieber; Enno Schmidt; Tamás Laskay; Andreas Recke; S Goletz; Gestur Vidarsson; Franziska S Schulze; Mikko Armbrust; Katharina Schulze Dieckhoff; Hendri H Pas; Marcel F Jonkman; Kathrin Kalies; Detlef Zillikens; Yask Gupta; Saleh M Ibrahim; Ralf J Ludwig
Journal:  Front Immunol       Date:  2018-02-15       Impact factor: 7.561

5.  The Immunometabolomic Interface Receptor Hydroxycarboxylic Acid Receptor 2 Mediates the Therapeutic Effects of Dimethyl Fumarate in Autoantibody-Induced Skin Inflammation.

Authors:  Melanie Wannick; Julian C Assmann; Jakob F Vielhauer; Stefan Offermanns; Detlef Zillikens; Christian D Sadik; Markus Schwaninger
Journal:  Front Immunol       Date:  2018-08-14       Impact factor: 7.561

6.  Perspective From the 5th International Pemphigus and Pemphigoid Foundation Scientific Conference.

Authors:  Jinmin Lee; Victoria P Werth; Russell P Hall; Rüdiger Eming; Janet A Fairley; David C Fajgenbaum; Karen E Harman; Marcel F Jonkman; Neil J Korman; Ralf J Ludwig; Dedee F Murrell; Philippe Musette; Haley B Naik; Christian D Sadik; Jun Yamagami; Marc L Yale; Aimee S Payne
Journal:  Front Med (Lausanne)       Date:  2018-11-08

7.  Blocking IL-10 receptor signaling ameliorates Mycobacterium tuberculosis infection during influenza-induced exacerbation.

Authors:  Sarah Ring; Lars Eggers; Jochen Behrends; Adam Wutkowski; Dominik Schwudke; Andrea Kröger; Alexandra Maximiliane Hierweger; Christoph Hölscher; Gülsah Gabriel; Bianca E Schneider
Journal:  JCI Insight       Date:  2019-04-18

8.  Implications of Anti-Inflammatory Nature of Exosomes in Knee Arthritis.

Authors:  William Fang; C Thomas Vangsness
Journal:  Cartilage       Date:  2020-02-13       Impact factor: 3.117

9.  Oral administration of the selective GPR120/FFA4 agonist compound A is not effective in alleviating tissue inflammation in mouse models of prototypical autoimmune diseases.

Authors:  Melanie Wannick; Siegfried Bezdek; Nathalie Guillen; Markus Thieme; Fibi Meshrkey; Sadegh Mousavi; Michaela Seeling; Falk Nimmerjahn; Attila Mócsai; Detlef Zillikens; Tanya Sezin; Christian D Sadik
Journal:  Pharmacol Res Perspect       Date:  2018-11-08

Review 10.  Epidermolysis Bullosa Acquisita: The 2019 Update.

Authors:  Hiroshi Koga; Catherine Prost-Squarcioni; Hiroaki Iwata; Marcel F Jonkman; Ralf J Ludwig; Katja Bieber
Journal:  Front Med (Lausanne)       Date:  2019-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.